Brett Sandercock - Aug 10, 2022 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Financial Officer
Signature
Brett Sandercock, Chief Financial Officer
Stock symbol
RMD
Transactions as of
Aug 10, 2022
Transactions value $
-$457,250
Form type
4
Date filed
8/12/2022, 12:11 PM
Previous filing
Jul 26, 2022
Next filing
Aug 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Options Exercise $144K +2.5K +2.35% $57.76 109K Aug 10, 2022 Direct F1
transaction RMD ResMed Common Stock Sale -$602K -2.5K -2.3% $240.66 106K Aug 10, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Options Exercise $0 -2.5K -100% $0.00* 0 Aug 10, 2022 ResMed Common Stock 2.5K $57.76 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.
F2 Represents date options first became exercisable. Options vest 1/3 per year.